Facebook Twitter LinkedIn Google Plus RSS

Deals and Moves: Oct. 8

By ,

Drug manufacturing partnership, generics acquisition approval, employee benefits merger.


Parsippany-based DSM Pharmaceutical Products, the manufacturing and technology arm of Royal DSM, today announced it has formed a partnership with England-based drug developer Almac Group Ltd. to provide sustainable technologies for its clients to manufacture active pharmaceutical ingredients.

Drugmaker Watson Pharmaceuticals Inc., in Parsippany, announced Friday it has received approval from the European Commission for its pending acquisition of Switzerland-based generics manufacturer Actavis Group for $5.6 billion.


Employee consulting firm Benefit Sources and Solutions, in Bound Brook, announced Friday it has merged with the employee benefits arm of The Chadler Group, in Fairfield, to expand its retirement plan services for small and midsized employers.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy